Holdings of Amplify Weight Loss Drug & Treatment ETF
Amplify ETF Trust · Original filing · Compare with another fund · Report an error
- Net assets
- 4.4M $ including 4.3M $ in equities, 97.4 %
- Positions
- 20 in 7 countries
- Top ten
- 60.2 % of net assets
- Filed on
- Jun 30, 2026
Portfolio shape
Positions
| Rank | Company | Shares | Value | Weight |
|---|---|---|---|---|
| 1 | Novo Nordisk A/S | 8,881 | 425.8K $ | 9.76 % |
| 2 | Eli Lilly & Co | 337 | 404.2K $ | 9.26 % |
| 3 | Scholar Rock Holding Corp | 4,531 | 249.2K $ | 5.71 % |
| 4 | Hims & Hers Health Inc | 7,013 | 243.1K $ | 5.57 % |
| 5 | Viking Therapeutics Inc | 6,142 | 239.6K $ | 5.49 % |
| 6 | AbbVie Inc | 901 | 226.7K $ | 5.20 % |
| 7 | Arrowhead Pharmaceuticals Inc | 2,722 | 221.9K $ | 5.08 % |
| 8 | Innovent Biologics Inc | 21,500 | 218.2K $ | 5.00 % |
| 9 | Amgen Inc | 552 | 199.9K $ | 4.58 % |
| 10 | Chugai Pharmaceutical Co Ltd | 4,300 | 199.3K $ | 4.57 % |
| 11 | Merck & Co Inc | 1,550 | 199.2K $ | 4.56 % |
| 12 | AstraZeneca PLC | 1,049 | 198.9K $ | 4.56 % |
| 13 | Roche Holding AG | 478 | 197.2K $ | 4.52 % |
| 14 | Regeneron Pharmaceuticals Inc | 314 | 195.8K $ | 4.49 % |
| 15 | CSPC Pharmaceutical Group Ltd | 220,000 | 195.5K $ | 4.48 % |
| 16 | Pfizer Inc | 7,957 | 191.6K $ | 4.39 % |
| 17 | Zealand Pharma A/S | 3,434 | 152.1K $ | 3.49 % |
| 18 | Kailera Therapeutics Inc | 4,864 | 107.2K $ | 2.46 % |
| 19 | JIANGSU HENGRUI PHARMACEUTICALS CO LTD | 13,400 | 98.9K $ | 2.27 % |
| 20 | Hanmi Pharm Co Ltd | 341 | 87.5K $ | 2.00 % |
Sector breakdown
- Health care 52.7 %
- Unattributed 47.3 %
Titelia assigns each company to a sector, one by one. The unassigned share stays visible, under "Unattributed".
Currency breakdown
- USD 73.0 %
- HKD 12.1 %
- JPY 4.7 %
- CHF 4.6 %
- DKK 3.6 %
- KRW 2.1 %
Each line is counted in its quoted currency, as the fund declares it.
Country breakdown
- United States 58.3 %
- Denmark 13.6 %
- Hong Kong SAR China 12.1 %
- Japan 4.7 %
- United Kingdom 4.7 %
- Switzerland 4.6 %
- South Korea 2.1 %
Shares are computed on the fund's equities only.
| Rank | Country | Lines | Value | Share |
|---|---|---|---|---|
| 1 | United States | 11 | 2.5M $ | 58.29 % |
| 2 | Denmark | 2 | 577.9K $ | 13.59 % |
| 3 | Hong Kong SAR China | 3 | 512.6K $ | 12.06 % |
| 4 | Japan | 1 | 199.3K $ | 4.69 % |
| 5 | United Kingdom | 1 | 198.9K $ | 4.68 % |
| 6 | Switzerland | 1 | 197.2K $ | 4.64 % |
| 7 | South Korea | 1 | 87.5K $ | 2.06 % |
Cite this page
Titelia. "Holdings of Amplify Weight Loss Drug & Treatment ETF". https://titelia.com/en/funds/S000085024